JKJill E. Keeffe

Jill E. Keeffe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jill E. Keeffe has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effective mobility framework: A tool for designing comprehensive O&M outcomes research

    by Lil Deverell, Sharon A. Bentley, Lauren N. Ayton, Clare Delany, Jill E. Keeffe

    In orientation and mobility (O&M) outcomes research, the concept of mobility has become narrowed to what can be captured with existing measures and methods. However, travel speed and contact tallies have not provided convincing evidence of functional changes resulting from O&M programs or such vision restoration treatments as retinal prostheses. This study used grounded theory methodology to develop a new understanding of mobility from expert opinions, including O&M specialists (n=15) and adults (n=40) with advanced retinitis pigmentosa. The Effective Mobility Framework includes the elements of Utility, Access, Orientation, Interdependence, Self-regulation, Efficiency, and Pleasure representing a more comprehensive understanding of O&M outcomes than previously used. The Framework highlights the importance of mixed methods data collection and the need for new types of ordinal measure in researching functional outcomes.


  • Open Access

    Erratum. Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990–2010. Diabetes Care 2016;39:1643–1649

    by Janet L. Leasher, Rupert R.A. Bourne, Seth R. Flaxman, Jost B. Jonas, Jill Keeffe, Novin Naidoo, Konrad Pesudovs, Holly Price, Richard A. White, Tien Y. Wong, et al.

    In the article listed above, there is an error in Table 1. The value for “Number …


  • Top Cited Papers
    Open Access

    Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010

    by Janet L. Leasher, Rupert R.A. Bourne, Seth R. Flaxman, Jost B. Jonas, Jill Keeffe, Kovin Naidoo, Konrad Pesudovs, Holly Price, Richard A. White, Tien Y. Wong, et al.

    OBJECTIVE: To estimate global and regional trends from 1990 to 2010 of the prevalence and number of persons visually impaired specifically by diabetic retinopathy (DR), as a complication of the precipitous trends in global diabetes, is fundamental for health planning purposes. RESEARCH DESIGN AND METHODS: The meta-analysis of published population studies from 1990 to 2012 for the Global Burden of Disease Study 2010 (GBD) yielded estimated global regional trends in DR among other causes of moderate and severe vision impairment (MSVI; presenting visual acuity <6/18, ≥3/60) and blindness (presenting visual acuity <3/60). RESULTS: Globally in 2010, out of overall 32.4 million blind and 191 million visually impaired people, 0.8 million were blind and 3.7 million were visually impaired because of DR, with an alarming increase of 27% and 64%, respectively, spanning the two decades from 1990 to 2010. DR accounted for 2.6% of all blindness in 2010 and 1.9% of all MSVI worldwide, increasing from 2.1% and 1.3%, respectively, in 1990. These figures were lower in regions with younger populations (4%). CONCLUSIONS: The number of persons with visual impairment due to DR worldwide is rising and represents an increasing proportion of all blindness/MSVI causes. Age-standardized prevalence of DR-related blindness/MSVI was higher in sub-Saharan Africa and South Asia. One out of 39 blind people had blindness due to DR, and 1 out of 52 visually impaired people had visual impairment due to DR.


  • Patient Perspectives on Acquiring Spectacles

    by Gail Melva Ormsby, Dawn Grant-Skiba, Kovin Naidoo, Jill E. Keeffe

    The Asia-Pacific Journal of Ophthalmology (APJO) is the official publication of the Asia-Pacific Academy of Ophthalmology. The APJO positions itself as a first-class bimonthly (6 issues per year) peer-viewed e-journal representative of ophthalmic and visual science developments in the Asia-Pacific region. The APJO welcomes the submission of original, previously unpublished manuscripts which describe clinical investigations, clinical observations and clinically relevant laboratory investigations.


  • Visual Impairment and Blindness Due to Macular Diseases Globally: A Systematic Review and Meta-Analysis

    by Jost B. Jonas, Rupert R.A. Bourne, Richard A. White, Seth R. Flaxman, Jill Keeffe, Janet Leasher, Kovin Naidoo, Konrad Pesudovs, Holly Price, Tien Y. Wong, et al.


  • Prevalence and causes of vision loss in sub-Saharan Africa: 1990–2010

    by Kovin Naidoo, Stephen Gichuhi, María-Gloria Basáñez, Seth R Flaxman, Jost B Jonas, Jill Keeffe, Janet L Leasher, Konrad Pesudovs, Holly Price, Jennifer L Smith, et al.

    Aim To estimate the magnitude, temporal trends and subregional variation in the prevalence of blindness, and moderate/severe vision impairment (MSVI) in sub-Saharan Africa. Methods A systematic review was conducted of published and unpublished population-based surveys as part of the Global Burden of Disease, Risk Factors and Injuries Study 2010. The prevalence of blindness and vision impairment by country and subregion was estimated. Results In sub-Saharan Africa, 52 studies satisfied the inclusion criteria. The estimated age-standardised prevalence of blindness decreased by 32% from 1.9% (95% CI 1.5% to 2.2%) in 1990 to 1.3% (95% CI 1.1% to 1.5%) in 2010 and MSVI by 25% from 5.3% (95% CI 0.2% to 0.3%) to 4.0% (95% CI 0.2% to 0.3%) over that time. However, there was a 16% increase in the absolute numbers with blindness and a 28% increase in those with MSVI. The major causes of blindness in 2010 were; cataract 35%, other/unidentified causes 33.1%, refractive error 13.2%, macular degeneration 6.3%, trachoma 5.2%, glaucoma 4.4% and diabetic retinopathy 2.8%. In 2010, age-standardised prevalence of MSVI in Africa was 3.8% (95% CI 3.1% to 4.7%) for men and 4.2% (95% CI 3.6% to 5.3%) for women with subregional variations from 4.1% (95% CI 3.3% to 5.4%) in West Africa to 2.0% (95% CI 1.5% to 3.3%) in southern Africa for men; and 4.7% (95% CI 3.9% to 6.0%) in West Africa to 2.3% (95% CI 1.7% to 3.8%) in southern Africa for women. Conclusions The age-standardised prevalence of blindness and MSVI decreased substantially from 1990 to 2010, although there was a moderate increase in the absolute numbers with blindness or MSVI. Significant subregional and gender disparities exist.


  • Costs of Vision Impairment in Childhood and Youth: Diary Case Studies

    by Patricia M. O'COnnor, Shiao‐Lan Chou, Ecosse L. Lamoureux, Jill E. Keeffe

    Purpose.: Children and youth with vision impairment face a lifetime of vision‐related costs. This paper examines the little‐known personal costs incurred in these early years. Methods.: Case studies of three children and one youth with vision impairment were extracted from a larger, diary‐based prospective study of the personal expenditure of people with vision impairment. Diaries were maintained over a 12 month period and expenditure and resource utilization were recorded under four main headings: medicines, products and equipment; health and community services; informal care and support; and other expenses. Results.: The scale of direct and indirect costs incurred differed by age at onset and duration of vision impairment. The highest personal costs were accrued for equipment. Informal care and support accounted for the highest indirect costs listed. Reliance on family meant that opportunity costs of relatives rather than out‐of‐pocket personal costs applied. Assistance from family members was consistently required in relation to transport, personal affairs, and reading‐related tasks. Minimal costs were recorded for medicines. Usage of low vision services was commonplace, reflecting the cost‐free availability of low vision rehabilitation and support services for children and youths in Australia. Conclusions.: This exploratory study draws attention to the complexity of factors that need to be considered when calculating the personal costs of vision impairment. Cross case comparisons showed that some personal costs were recurrent, others sporadic or once‐off. By highlighting the role that age, onset and duration of vision loss, life/educational stage and lifestyle played in differentiating costs between case study participants, these diaries represent important formative work that can guide future research in this area.


  • Assessment of trachoma prevalence in a mobile population in Central Australia

    by Van C. Lansingh, LeAnn M. Weih, Jill E. Keeffe, Hugh R. Taylor

    Trachoma is reported to be hyperendemic in Australia. This study was conducted in a desert area of Central Australia to implement and evaluate the WHO SAFE strategy to control trachoma. The aim of ...


  • Recruitment methods for community-based screening for diabetic retinopathy

    by S.J. Lee, C.A. McCarty, C. Sicari, C.A. Harper, H.R. Taylor, J.E. Keeffe, P.M. Livingston


  • Diabetic retinopathy: examination practices and referral patterns of general practitioners

    by Peter R Dickson, Catherine A McCarty, Jill E Keeffe, Royce Baxter, C Alex Harper, Hugh R Taylor

    Objective To investigate general practitioners’ (GPs') examination and referral practices for diabetic retinopathy. Methods A questionnaire survey of a random stratified sample of 500 Victorian GP...